U.S. launch expected in early February – – Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drive ...

With better risk stratification, clinicians may be able to optimize medical management of patients with chronic HBV who don’t ...

Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

HEPLISAV-B® net product revenue grew 26% year-over-year to approximately $268 million Enrollment completed in Phase 1/2 shingles trial; top line ...

Immunosuppressants work to reduce an overactive immune system, but they weaken the immune response, making people who take them more susceptible to illness. Talk to your healthcare provider about the ...

From the Department of Cardiology and Angiology I, University Heart Center Freiburg, Germany (D.W.) Faculty of Medicine, University of Freiburg, Germany (D.W.) K. Ley has received research funding for ...

No wonder surveillance is being beefed up. up. In response to the Christmas Day incident, Nato Secretary-General Mark Rutte tweeted on 27 December that it “will enhance its military presence in ...

Watson (knee) didn't practice Wednesday. Watson hasn't practiced since suffering a left knee bruise in the Packers' Week 16 win over the Saints, but he was listed as questionable ahead of this ...

The number of annual holidays is determined by statute. Please refer to SAM policy 02.E.03 section 3.8, to review the process for observing optional holidays Rosh Hashanah, Yom Kippur, Cesar Chavez ...

D) Overview of DALI pipelines using either -1-loading of the R Seurat object and immune ... and 10 µg CpG as adjuvant. In the vaccine immunisation strategy, 2 µg of the COMIRNATY (BNT162b2) vaccine ...

Rationalized selection of responsive TCR clones by single-cell analysis to aid in the generation of novel TCR transgenic animals.